Regarding IL-8, 29/30 (96.7%) HCC patients had IL-8 level < 345 pg/ml compared to only 4/17 cases with PNALT, whereas most PNALT patients had IL-8 ≥ 345 pg/ml (p = 0.000). This evidence concerns the gene CXCL8 and hepatocellular carcinoma.